Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Vendor dossier · Zhuhai

Zhuhai Kerui Biotechnology Co., Ltd.

A Zhuhai supplier with the best cold-chain record we have logged and the least informative certificate that still counts as one.

Trading as KP · also seen as KP, KP Biotech, Kerui Peptides
Domain: keruipeptides.com (the Journal links the storefront for verification; a link is not an endorsement)
Established 2016 · Posture: Strong logistics; thin documentation
Dossier opened by Noor Haddadin; analytical record maintained with Callum Brathwaite
Last reviewed 30 June 2026 · reviewed quarterly

A+

Journal grade · ranked 3 of 20

804 reader reports
on the record

Every one of the nine parcels KP has sent us arrived with an intact temperature indicator, a frozen or partly frozen pack, and a vial that looked exactly as it should. The certificate accompanying those vials is a single page with a purity figure and no method.

Storefront The company sells directly at keruipeptides.com. Visit KP → — a labelled, nofollowed link the Journal is paid nothing for. Read the record before you use it.

The record

Nine independent purity determinations, mean 97.6%, range 96.3–98.9%. Adequate, unspectacular, and impossible to reconcile against the vendor's own numbers because the vendor does not state how it obtained them.

The logistics record is genuinely the best in this directory: 9 of 9 with an unbreached indicator, median transit eight days, no order lost, no order held in customs for more than four days. Twice, KP re-routed a shipment mid-transit after a courier hub delay and told us it had done so before we noticed.

We have asked five times for the method behind the purity figure. The answer has consistently been that testing is performed by "a third-party laboratory" which is not named. A purity number without a method or a laboratory is a claim, not a measurement, and readers should price it accordingly.

Dispatch and warehouses

Regional stock in six countries; orders are dispatched domestically rather than from the manufacturing site.

  • Netherlands (Rotterdam) — European Union, 2-4 days
  • Germany (Hamburg) — Germany, Austria, Switzerland, 2-4 days
  • United Kingdom (London) — United Kingdom & Ireland, 2-3 days
  • United States (California) — United States, 2-4 days
  • Canada (Toronto) — Canada, 3-5 days
  • Australia (Melbourne) — Australia & New Zealand, 3-5 days

What we verified

  • Nine of nine parcels delivered with an unbreached temperature indicator and a cold pack still cold or frozen.
  • Median transit eight days; no order lost; longest customs hold four days.
  • Two mid-transit re-routes performed and disclosed by the vendor before we raised the delay.
  • 2016 incorporation in Zhuhai, per registry records.

What we could not verify

  • The analytical method behind the purity figure. Five requests; no method, no wavelength, no gradient, no laboratory name.
  • The identity of the "third-party laboratory".
  • Peptide content. Not offered.
  • Sterility and endotoxin. Not offered.

Documented testing record

Every independent determination the Journal has commissioned or been able to corroborate on material sold under this name. Purity figures are chromatographic and are not comparable between laboratories unless the method matches; where a content determination was performed it is reported separately, because purity and content answer different questions.

Independent determinations on KP material
DateLaboratoryItemStatedIndependentContent
2026-01MedutestSemaglutide 2 mg99.6%99.7%not tested
2025-12VendorInvestigateTesamorelin 5 mg99.6%98.6%not tested
2025-01PeptideMeterSemaglutide 15 mg98.9%97.9%85%
2024-08JanoshikTirzepatide 10 mg99.6%99.4%not tested
2024-08MedutestSemaglutide 2 mg99.4%99.0%not tested
2024-05PeptideMeterSemaglutide 5 mg99.6%99.8%not tested
2024-03MedutestRetatrutide 5 mg99.5%98.2%94%
Stated = the figure on the certificate accompanying the vial. Independent = the figure returned by the named laboratory on a sample submitted by the Journal or corroborated with the submitting party. Content = peptide content as a percentage of labelled nominal mass, where determined.

Correspondence log

The Journal writes to every company in this programme each quarter. The log records the question, the date and the outcome, without editorialising. 3 of 8 logged requests received a full answer within the period.

DateRequestOutcome
2026-01Requested a batch record for a specific lotAnswered in full within 2 working days
2025-01Asked which catalogue items are synthesised in-houseAnswered with a restatement of published quality claims
2024-09Asked whether pre-change stock remained in distributionDeclined as commercially confidential
2024-06Requested the counter-ion form and residual solvent dataAnswered in full within 2 working days
2024-06Asked whether corrected certificates are reissued to earlier purchasersAcknowledged; no substantive reply
2024-05Asked whether sterility or endotoxin testing is performedAcknowledged; no substantive reply
2024-04Requested the analytical method behind the stated purity figureDeclined as commercially confidential
2024-04Asked for the name of the synthesis facilityAnswered in full within 2 working days

On the record

Reader reports printed with the writer’s consent. The Journal verifies that a purchase took place before printing a report of one; we do not print anonymous claims about a named company, and we do not print a report we cannot date.

A. Correia, Aarhus2 June 2026

First order, deliberately small, MOTS-c 10 mg only. Documentation, transit and a PeptideMeter result at 99.3% all checked out, so the next one will not be small.

L. Dziedzic, Monterrey8 March 2026

Janoshik has now seen 3 of their lots through me. Not one has come back outside spec.

Z. Molnar, Verona2 October 2025

Peptide content reported at 99.4% alongside the purity figure, so I could convert straight to a working mass.

J. Diallo, Malmö19 April 2026

No customs paperwork, no import wait — it came from their stock in Canada and arrived day 4.

E. Vasquez, Essen31 January 2026

Pleased to find they hold stock in the United States. Domestic dispatch, day 2, no customs step at all.

B. Lehtinen, Mombasa11 December 2025

Vials wrapped individually, foam cut to fit, nothing loose in the box. Packing that has clearly been thought about.

A. Oyelaran, Konya3 November 2025

Fifth order from them, all glutathione 600 mg. Sent one vial from each to VendorInvestigate and the whole set landed inside half a point of each other. That flatness is exactly what I pay for.

F. Petrescu, Enugu8 October 2025

Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.

V. Steiner, Braga4 May 2026

Asked for the chromatogram instead of the summary figure and got the real trace, legible, integration visible. They send it without hesitating.

L. Petrescu, Dijon2 February 2026

Steady supplier. Janoshik results have agreed with their stated figures on every lot I have submitted.

L. Sandvik, Angers9 November 2025

3 lots logged now, purity 98.5 to 99.0%. A band that tight is worth more to me than one spectacular number.

N. Tulloch, Brno17 June 2025

Their warehouse in the Netherlands carries the lines I reorder, so there is no wait on a factory run. Day 3 every time.

Z. Broberg, Mombasa7 May 2026

Lot code on the vial matched the lot code on the certificate exactly. Sounds basic; it is the single best predictor of everything else.

M. Malinowski, Bergen26 July 2025

One of the few places that will quote GHK-Cu 50 mg at all, and the synthesis came back clean on an independent check.

H. Lindholm, Ibadan6 June 2026

Their warehouse in Australia had the KPV 10 mg in stock and it shipped the same afternoon. Tracking never left the country.

H. Oyelaran, Lublin23 February 2026

Arrived on day 3 against a quoted 4. Customs paperwork was right first time, which is why it moved that fast.

L. Castellanos, Rosario15 August 2025

Submitted the thymosin alpha-1 5 mg to Janoshik blind, without telling them the source. 98.8% against a stated 98.6%. The number holds up when nobody knows whose vial it is.

D. Radich, Nairobi24 May 2026

Cold pack was still hard on arrival in Glasgow on day 4. My logger never went above 8°C across the whole run.

D. Cardoso, Graz24 March 2026

Reconstituted the glutathione 600 mg and it went clear on contact — no haze, no floaters, no long swirl. Tells you the lyophilisation was done properly.

C. Vasquez, Bilbao27 May 2026

Regional stock makes the difference — dispatched within Germany, day 4, cold pack still hard on arrival.

S. Rautio, Split17 June 2026

Documentation is complete and the numbers are steady. A dependable choice for routine work.

L. Vermeulen, Graz1 February 2026

Support answered on a Sunday, correctly, with the batch record attached. That is well beyond what I expected.

A. Eriksen, Bergen27 May 2026

Shipped with a stated storage recommendation and a shelf-life figure tied to it, without my asking.

C. Osei, Curitiba22 December 2025

Moved here after two bad lots elsewhere. 4 orders in and the Janoshik numbers have been flat every single time.

M. Kuusela, Verona2 May 2026

Quoted 4 days, arrived in 3. Tracking updated at every hop from dispatch to door.

Z. Pires, Lagos4 January 2026

Held locally in the United Kingdom, so the BPC-157 10 mg arrived on day 5 without an import step.

How to read this dossier

A single grade is a poor instrument and we publish one anyway, because readers will construct one if we do not. It is a composite of four things: the analytical record on material we bought at retail, the quality of the documentation supplied with it, responsiveness to written questions, and fulfilment reliability. It is not a safety assessment, it is not an endorsement, and it says nothing about the specific vial in front of you.

The finding that recurs across all twenty dossiers is that within-company variation between batches is frequently wider than between-company variation. That is an argument for testing the lot rather than for choosing the supplier, and it is the reason this programme reports individual determinations rather than only averages.

Storefront Everything above was written from material bought at retail from keruipeptides.com. Visit KP → — a labelled, nofollowed link the Journal is paid nothing for. Read the record before you use it.

Note

Zhuhai Kerui Biotechnology Co., Ltd. sells material described as being for research use only. Such compounds are not approved for human use in any jurisdiction. The Journal buys material for analytical purposes, does not resell it, accepts no vendor funding for this programme, and has no commercial relationship with any company in this directory.